We strive for a modern diagnostics experience, suitable for today’s at-home medical revolution, accessible for all and easy to use. Our novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes. Our proprietary technology offers PCR grade accuracy with rapid home testing conveniency, enabling an end-to-end solution for diagnosis of bacterial and viral infections anywhere and anytime.
| Employees | 7 (4 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
Looking for a particular Kanso Diagnostics employee's phone or email?
Roy Rabinowitz is the CEO and Co-Founder of Kanso Diagnostics.
4 people are employed at Kanso Diagnostics.